A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an ...

Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression profiling, and clinical research. By refining probe design and ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

According to research by SNS Insider, the U.S. Cell Analysis Market is projected to grow at a CAGR of 9.77%, Fueled by strong biotechnology capabilities, expanding precision medicine initiatives & ...

The role of postmastectomy chest-wall irradiation in patients with breast cancer classified as pN1 (with involvement of one to three axillary nodes) or pN0 (pathologically node negative) with ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

Drinking tea and coffee could lead to improved cancer outcomes for patients, thanks to the beverages potentially playing a “protective role” against the disease. Specifically, high coffee and/or tea ...

Dr. Grande's YouTube Channel covers topics related to counselor education and supervision including but not limited to mental health, human behavior, relationship dynamics, psychopathology, ...

Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 trial.